Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Integrated Transcriptomic-Proteomic Analysis Revealed the Diagnostic and Potential Therapeutic Targets of Colorectal Cancer

ABSTRACT: Integrated Transcriptomic-Proteomic Analysis Revealed the Diagnostic and Potential Therapeutic Targets of Colorectal Cancer

PROVIDER: PRJNA822834 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18590539_1.fastq.gz	Fastqsanger.gz
	SRR18590539_2.fastq.gz	Fastqsanger.gz
	SRR18590540_1.fastq.gz	Fastqsanger.gz
	SRR18590540_2.fastq.gz	Fastqsanger.gz
	SRR18590541_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Integrated Transcriptomic-Proteomic Analysis Revealed the Diagnostic and Potential Therapeutic Targets of Colorectal Cancer

Project description:To identify the potential biomarkers related to the development of colorectal cancer.we established an inflammation-induced colorectal cancer disease model in mice.

2022-12-31 | GSE200076 | GEO

An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms

Project description:An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms

| PRJNA514255 | ENA

Involvement of autophagy in mesaconitine-induced neurotoxicity in HT22 cells revealed through integrated transcriptomic, proteomic, and m6A epitranscriptomic profiling

Project description:Involvement of autophagy in mesaconitine-induced neurotoxicity in HT22 cells revealed through integrated transcriptomic, proteomic, and m6A epitranscriptomic profiling

| PRJNA1086484 | ENA

Integrated transcriptomic and proteomic analysis revealed the inhibition mechanism of a natural luvangetin from Zanthoxylum avicennae against Fusarium verticillioides

Project description:Integrated transcriptomic and proteomic analysis revealed the inhibition mechanism of a natural luvangetin from Zanthoxylum avicennae against Fusarium verticillioides

| PRJNA1037161 | ENA

Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy.

Project description: Not available

| S-EPMC8503648 | biostudies-literature

Integrated transcriptomic and proteomic analysis of human eccrine sweat glands

Project description:Integrated transcriptomic and proteomic analysis of human eccrine sweat glands

| PRJNA483486 | ENA

Integrated multi-omics approach revealed cellular senescence landscape

Project description:Integrated multi-omics approach revealed cellular senescence landscape

| PRJNA865031 | ENA

Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses

Project description:Personalized cancer therapy based on the somatic mutations identified in patient tumors is becoming an increasingly emphasized approach to improve outcomes of patients with cancer. There are also examples of therapeutic vulnerabilities in cancer that result from changes in gene expression that are a direct or indirect result of tumor specific epigenetic perturbations. These genomic and epigenomic changes are ultimately manifest in the tumor proteome and phosphoproteome. In this study, we integrated genomic, epigenomic and proteomic data for rhabdomyosarcoma (RMS) to identify therapeutic vulnerabilities. RMS was selected for this analysis because RAS pathway mutations in rhabdomyosarcoma (RMS) are the most common potentially actionable lesions across pediatric solid tumors. The epigenomic data was useful for identifying deregulated developmental pathways in RMS including the WNT, HH, BMP, adenyl cyclase, p38/MAPK and PI3K pathways. Perturbations in those 6 myogenic signal transduction pathways were also evident in the proteome and phosphoteome data. In addition, the proteomic/phosphoproteomic data revealed that the cell cycle checkpoint, unfolded protein response and RB/E2F pathways were deregulated in RMS relative to normal muscle. Recent success targeting CDK4/6 and MEK in adult cancers with RAS mutations led us to test the value of these targets in RMS tumors. We also targeted the unfolded protein response pathway and cell cycle checkpoint pathway using molecular targeted therapeutics in orthotopic patient derived xenografts. Taken together, these data demonstrate the value of integrating epigenomic and proteomic data to identify tumor vulnerabilities that extend beyond somatic mutations identified in the genome.

| EGAS00001002967 | EGA

Metabolic Reprogramming in Hepatocellular Carcinoma: An Integrated Omics Study of Lipid Pathways and Their Diagnostic Potential

Project description:Metabolic Reprogramming in Hepatocellular Carcinoma: An Integrated Omics Study of Lipid Pathways and Their Diagnostic Potential

2025-03-20 | PXD062049 |

Integrated transcriptomic and proteomic analysis of primary human umbilical vein endothelial cells

Project description:Integrated transcriptomic and proteomic analysis of primary human umbilical vein endothelial cells

| PRJNA475283 | ENA